Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 14, 2009Proceedings of the National Academy of SciencesOpen Access

Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression

View Full Paper
Ask AI
Bookmark
Share

Authors

CKChristopher R. KimberlinPfizer (United States)ZBZachary A. BornholdtMapp Biopharmaceutical (United States)SLSheng LiSun Yat-sen University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kimberlin et al. (2009) studied this question.

synapsesocial.com/papers/6a78b6872e130d02afed47e2https://doi.org/10.1073/pnas.0910547107
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 32003 · 477 citations
  2. 2The VP35 Protein of Ebola Virus Inhibits the Antiviral Effect Mediated by Double-Stranded RNA-Dependent Protein Kinase PKR2006 · 177 citations
  3. 3Optimal description of a protein structure in terms of multiple groups undergoing TLS motion2006 · 1,274 citations